Related Experiment Video
Updated: Aug 4, 2026
09:57
System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
In vitro activity of thienamycin
Methods and Findings in Experimental and Clinical Pharmacology
|November 1, 1981
Summary
Thienamycin demonstrated potent in vitro antibacterial activity, especially in peptone broth, inhibiting most gram-negative bacteria at low concentrations. This highlights the crucial role of culture media in determining antibiotic efficacy.
Area of Science:
- Microbiology
- Pharmacology
- Infectious Diseases
Background:
- Antibiotic resistance is a growing global health concern.
- Understanding the in vitro activity of novel antibiotics is crucial for effective treatment strategies.
- Culture media can significantly influence the observed antimicrobial activity of drugs.
Purpose of the Study:
- To evaluate the in vitro activity of thienamycin against gram-negative aerobic bacteria.
- To compare thienamycin's efficacy with existing antibiotics (aminoglycosides and cefalosporins).
- To investigate the impact of different culture media (Müller-Hinton broth and peptone broth) on thienamycin's activity.
Main Methods:
- Determining minimum inhibitory concentrations (MICs) and minimum bactericidal concentrations (MBCs) for thienamycin.
- Simultaneous testing in Müller-Hinton broth and peptone broth.
- Comparative analysis against four aminoglycosides and three cefalosporins.
Main Results:
- Thienamycin's in vitro activity was significantly influenced by the culture medium used.
- Peptone broth yielded lower MICs and MBCs compared to Müller-Hinton broth.
- At concentrations ≤ 8 mcg/ml in peptone broth, thienamycin inhibited 354 out of 382 tested gram-negative aerobic bacterial strains.
Conclusions:
- Thienamycin exhibits strong in vitro antibacterial activity against gram-negative aerobic bacteria.
- The choice of culture medium is a critical factor in assessing antibiotic potency.
- Peptone broth appears to be a more suitable medium for evaluating thienamycin's efficacy in vitro.
